Management of Other Gastric and Duodenal Neuroendocrine Tumors.
Carcinoid tumor
Duodenal neuroendocrine tumor
Gastric neuroendocrine tumor
Neuroendocrine
Zollinger-Ellison syndrome
Journal
Surgical oncology clinics of North America
ISSN: 1558-5042
Titre abrégé: Surg Oncol Clin N Am
Pays: United States
ID NLM: 9211789
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
entrez:
11
3
2020
pubmed:
11
3
2020
medline:
12
8
2021
Statut:
ppublish
Résumé
Gastric and duodenal neuroendocrine tumors (NETs) are increasing in incidence as a result of increased detection and awareness of neuroendocrine tumors as distinct tumor types. The three types of gastric NETs and duodenal NETs have different etiologies and tumor-specific factors, such as grade, location, and hormone-production, and the clinical settings influence management. Options for treatment include removal by local endoscopic resection and surgical resection. Medical therapy is used to treat the inciting condition or as systemic therapy in advanced disease. Although the overall prognosis for most is good, higher grade tumors behave aggressively and have reduced survival.
Identifiants
pubmed: 32151359
pii: S1055-3207(19)30105-X
doi: 10.1016/j.soc.2019.11.009
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
253-266Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure The authors have nothing to disclose.